| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8647543 | Multiple Sclerosis and Related Disorders | 2018 | 18 Pages |
Abstract
Fingolimod reduces clinical and radiological inflammation in MS. Additionally, it limits the clinical expression of new Gd + lesions, possibly reducing local inflammatory processes and improving brain network plasticity in patients with suboptimal response to IFNβâ1a.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Elisabetta Signoriello, Doriana Landi, Fabrizia Monteleone, Francesco Saccà , Carolina Gabri Nicoletti, Fabio Buttari, Francesco Sica, Girolama Alessandra Marfia, Giuseppe Di Iorio, Giacomo Lus, Diego Centonze,